Clinical trials: Focal Hand Dystonia
Focal Dystonia
rTMS and Retraining in Focal Hand Dystonia
This study is exploring a new experimental procedure in dystonia called repetitive transcranial magnetic brain stimulation (TMS) combined with rehabilitation.
- Trial name
- DSS (NCT01738581)
- Testing
- Repetitive Transcranial Magnetic Stimulation, Sensorimotor Retraining, Non-specific Therapy
- Where
- 2 sites in United States
- Volunteers
- 9 people
- Sponsor
- University of Minnesota
Dystonia, Focal, Task-specific
Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia
This study investigated the short term effects of repeated administrations of repetitive-transcranial magnetic stimulation (rTMS) on clinical changes and investigate neurophysiologic responses to rTMS of the activated motor…
- Trial name
- NCT01884064
- Testing
- rTMS
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- University of Minnesota
Occupational; Cramp(s)
Study of Arm and Putter Movement in Golfers With Golfer's Cramp
The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.
- Trial name
- NCT02032758
- Testing
- Propranolol, Opal Device, Science and Motion PuttLab (SAM)
- Where
- United States
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
Isolated Focal Hand Dystonia
Neuromodulation Therapy for Task-Specific Dystonia
This study aims to apply a non-invasive brain stimulation technology called repetitive Transcranial Magnetic Stimulation (rTMS) in patients with focal hand dystonia (FHD).
- Trial name
- NCT06422104
- Testing
- Repetitive transcranial magnetic stimulation
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Duke University
Dystonia
Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand
The investigational drug being studied in this protocol is Incobotulinumtoxin A (Xeomin®). Botulinum toxin (BoNT) prevents the release of the acetylcholine from peripheral nerves, inhibiting muscle contractions.
- Trial name
- NCT02107261
- Testing
- incobotulinumtoxin A
- Where
- 2 sites in United States
- Volunteers
- 21 people
- Sponsor
- Icahn School of Medicine at Mount Sinai